19-Feb-2026 3:05 PM CST - Business Wire Tandem Diabetes Care Announces Fourth Quarter and Full Year 2025 Financial Results and 2026 Financial Guidance Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and fiscal year ended December 31, 2025 and provided its financial guidance for the year ending December 31, 2026. Fourth Quarter 2025 Financial and Strategic Highlights Achieved record quarterly sales: Worldwide sales of $290.4 million United States sales of $210.5 million Worldwide pump shipments of 38,000 United
12-Feb-2026 3:05 PM CST - Business Wire Tandem Diabetes Care Announces Upcoming Conference Presentations Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: Citis 2026 Unplugged MedTech and Life Sciences Access Day on Thursday, February 26, 2026 at 1:45pm Eastern Time (10:45am Pacific Time), TD Cowen 46th Annual Health Care Conference on Wednesday, March 4, 2026 at 9:10am Eastern Time (6:10am Pacific Time), and Oppenhei
8-Jan-2026 3:05 PM CST - Business Wire Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2025 results after the financial markets close on Thursday, February 19, 2026. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its fourth quarter and full year 2025 financial and operating results. A live webcast of the call w
6-Nov-2025 3:05 PM CST - Business Wire Tandem Diabetes Care Announces Third Quarter 2025 Financial Results Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2025 and reaffirmed full year 2025 guidance. Third Quarter 2025 and Recent Highlights Achieved record third quarter sales both in the United States (U.S.) and internationally Demonstrated year-over-year and sequential gross margin improvement Progressed multi-channel initiative by: Increasing ph
31-Oct-2025 3:05 PM CST - Business Wire Tandem Diabetes Care Announces Upcoming Conference Presentations Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: Stifel 2025 Healthcare Conference on Tuesday, November 11, 2025 at 10:40am Eastern Time (7:40am Pacific Time), and Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025 at 10:30am Eastern Time (7:30am Pacific Time). The presentations will be we
2-Oct-2025 3:05 PM CST - Business Wire Tandem Diabetes Care to Announce Third Quarter 2025 Financial Results on November 6, 2025 Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2025 results after the financial markets close on Thursday, November 6, 2025. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its third quarter 2025 financial and operating results. A live webcast of the call will be available on Tandem Diab
6-Aug-2025 3:05 PM CST - Business Wire Tandem Diabetes Care Announces Second Quarter 2025 Financial Results and Provides 2025 Annual Guidance Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2025 and provided full year 2025 guidance. Second Quarter 2025 Highlights Achieved record second quarter sales both in the United States (U.S.) and internationally. Demonstrated year-over-year and sequential gross margin improvement. Initiated an early access program for the t:slim X2 insulin pump w
31-Jul-2025 3:05 PM CST - Business Wire Tandem Diabetes Care Announces Upcoming Conference Participation Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will host meetings and present a company update at the following investor conferences: Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025 at 1:00pm Eastern Time (10:00am Pacific Time), and Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10, 2025 at 9:15am Eastern Time (6:15am Pa
1-Jul-2025 3:05 PM CST - Business Wire Tandem Diabetes Care to Announce Second Quarter 2025 Financial Results on August 6, 2025 Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2025 results after the financial markets close on Wednesday, August 6, 2025. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its second quarter 2025 financial and operating results. A live webcast of the call will be available on Tandem Dia
Latest TNDM Trades by Congress Members
22-SEP-2025 - Josh Gottheimer, NJ (District 5) purchased between $1,001 and $15,000.
19-Feb-2026 3:05 PM CST - Business Wire Tandem Diabetes Care Announces Fourth Quarter and Full Year 2025 Financial Results and 2026 Financial Guidance Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and fiscal year ended December 31, 2025 and provided its financial guidance for the year ending December 31, 2026. Fourth Quarter 2025 Financial and Strategic Highlights Achieved record quarterly sales: Worldwide sales of $290.4 million United States sales of $210.5 million Worldwide pump shipments of 38,000 United
12-Feb-2026 3:05 PM CST - Business Wire Tandem Diabetes Care Announces Upcoming Conference Presentations Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: Citis 2026 Unplugged MedTech and Life Sciences Access Day on Thursday, February 26, 2026 at 1:45pm Eastern Time (10:45am Pacific Time), TD Cowen 46th Annual Health Care Conference on Wednesday, March 4, 2026 at 9:10am Eastern Time (6:10am Pacific Time), and Oppenhei
8-Jan-2026 3:05 PM CST - Business Wire Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2025 results after the financial markets close on Thursday, February 19, 2026. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its fourth quarter and full year 2025 financial and operating results. A live webcast of the call w
6-Nov-2025 3:05 PM CST - Business Wire Tandem Diabetes Care Announces Third Quarter 2025 Financial Results Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2025 and reaffirmed full year 2025 guidance. Third Quarter 2025 and Recent Highlights Achieved record third quarter sales both in the United States (U.S.) and internationally Demonstrated year-over-year and sequential gross margin improvement Progressed multi-channel initiative by: Increasing ph
31-Oct-2025 3:05 PM CST - Business Wire Tandem Diabetes Care Announces Upcoming Conference Presentations Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: Stifel 2025 Healthcare Conference on Tuesday, November 11, 2025 at 10:40am Eastern Time (7:40am Pacific Time), and Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025 at 10:30am Eastern Time (7:30am Pacific Time). The presentations will be we
2-Oct-2025 3:05 PM CST - Business Wire Tandem Diabetes Care to Announce Third Quarter 2025 Financial Results on November 6, 2025 Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2025 results after the financial markets close on Thursday, November 6, 2025. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its third quarter 2025 financial and operating results. A live webcast of the call will be available on Tandem Diab
6-Aug-2025 3:05 PM CST - Business Wire Tandem Diabetes Care Announces Second Quarter 2025 Financial Results and Provides 2025 Annual Guidance Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2025 and provided full year 2025 guidance. Second Quarter 2025 Highlights Achieved record second quarter sales both in the United States (U.S.) and internationally. Demonstrated year-over-year and sequential gross margin improvement. Initiated an early access program for the t:slim X2 insulin pump w
31-Jul-2025 3:05 PM CST - Business Wire Tandem Diabetes Care Announces Upcoming Conference Participation Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will host meetings and present a company update at the following investor conferences: Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025 at 1:00pm Eastern Time (10:00am Pacific Time), and Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10, 2025 at 9:15am Eastern Time (6:15am Pa
1-Jul-2025 3:05 PM CST - Business Wire Tandem Diabetes Care to Announce Second Quarter 2025 Financial Results on August 6, 2025 Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2025 results after the financial markets close on Wednesday, August 6, 2025. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its second quarter 2025 financial and operating results. A live webcast of the call will be available on Tandem Dia
